Stay updated on Modulating Tumor Microenvironment in CRC Clinical Trial
Sign up to get notified when there's something new on the Modulating Tumor Microenvironment in CRC Clinical Trial page.

Latest updates to the Modulating Tumor Microenvironment in CRC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe MODULATE Phase II colorectal cancer trial record is displayed in place of an error page, with details about its treatments, eligibility, study locations, and outcomes.SummaryDifference56%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces NIH website updates and says that, during a transition, some NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check50 days agoChange DetectedRemoved the 403 Forbidden message and its surrounding HTML, and deleted the Home navigation item from the page.SummaryDifference0.5%

Stay in the know with updates to Modulating Tumor Microenvironment in CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Modulating Tumor Microenvironment in CRC Clinical Trial page.